K240398 is an FDA 510(k) clearance for the RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3. This device is classified as a System, Planning, Radiation Therapy Treatment (Class II - Special Controls, product code MUJ).
Submitted by RaySearch Laboratories AB (PUBL) (Stockholm, SE). The FDA issued a Cleared decision on April 4, 2025, 420 days after receiving the submission on February 9, 2024.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5050.